X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (607388) 607388
Newspaper Article (59479) 59479
Newsletter (51624) 51624
Magazine Article (3284) 3284
Conference Proceeding (2929) 2929
Book Chapter (2784) 2784
Dissertation (1906) 1906
Web Resource (810) 810
Publication (708) 708
Trade Publication Article (629) 629
Reference (230) 230
Book / eBook (193) 193
Transcript (177) 177
Government Document (140) 140
Book Review (69) 69
Journal / eJournal (37) 37
Paper (35) 35
Streaming Video (22) 22
Report (14) 14
Standard (12) 12
Data Set (1) 1
Library Holding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
glucose (327073) 327073
humans (247879) 247879
male (187933) 187933
animals (175797) 175797
female (152554) 152554
diabetes (117754) 117754
dextrose (114129) 114129
adult (91582) 91582
glucose - metabolism (87406) 87406
insulin (86635) 86635
middle aged (81665) 81665
rats (80192) 80192
glucose metabolism (79062) 79062
blood glucose - metabolism (77899) 77899
endocrinology & metabolism (76945) 76945
research (74113) 74113
metabolism (57544) 57544
blood glucose - analysis (57175) 57175
insulin resistance (53768) 53768
mice (49345) 49345
aged (48683) 48683
analysis (48190) 48190
physiological aspects (46304) 46304
insulin - blood (44525) 44525
obesity (43900) 43900
biochemistry & molecular biology (43274) 43274
risk factors (37649) 37649
type 2 diabetes (36756) 36756
diabetes mellitus (35395) 35395
glucose tolerance test (33482) 33482
time factors (31778) 31778
proteins (31600) 31600
insulin - metabolism (30656) 30656
glucose - pharmacology (29880) 29880
enzymes (28942) 28942
hyperglycemia (28280) 28280
blood glucose (27068) 27068
physiology (26760) 26760
expression (26098) 26098
adolescent (25644) 25644
insulin-resistance (25607) 25607
health aspects (23913) 23913
kinetics (23559) 23559
pregnancy (23122) 23122
body mass index (22530) 22530
biotechnology & applied microbiology (22368) 22368
oxidative stress (22208) 22208
pharmacology & pharmacy (22174) 22174
cell biology (21358) 21358
gene expression (20168) 20168
nutrition & dietetics (19776) 19776
diet (19687) 19687
research article (19459) 19459
neurosciences (19078) 19078
body weight (18778) 18778
insulin secretion (18652) 18652
diabetes mellitus, type 2 - blood (18491) 18491
studies (18191) 18191
risk (18110) 18110
rodents (18002) 18002
liver - metabolism (17742) 17742
care and treatment (17728) 17728
fasting (17685) 17685
disease (17295) 17295
mellitus (17282) 17282
blood pressure (16960) 16960
metabolic syndrome (16514) 16514
hypoglycemic agents - therapeutic use (16443) 16443
medicine (16437) 16437
prevalence (16379) 16379
rats, wistar (16307) 16307
cells, cultured (16279) 16279
diabetes mellitus, type 2 - drug therapy (16252) 16252
blood sugar (16212) 16212
liver (16204) 16204
insulin - pharmacology (15993) 15993
medicine, general & internal (15949) 15949
child (15820) 15820
rats, sprague-dawley (15724) 15724
medicine, research & experimental (15708) 15708
inflammation (15579) 15579
homeostasis (15485) 15485
medical research (15294) 15294
diabetes therapy (15102) 15102
lipids (15060) 15060
hypoglycemia (15031) 15031
apoptosis (14723) 14723
mortality (14670) 14670
phosphorylation (14542) 14542
fermentation (14525) 14525
cholesterol (14407) 14407
cells (14381) 14381
medicine & public health (14291) 14291
in vitro techniques (14183) 14183
microbiology (14139) 14139
triglycerides - blood (14104) 14104
exercise (14094) 14094
hypertension (13991) 13991
blood glucose - drug effects (13802) 13802
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (65) 65
Online Resources - Online (64) 64
University Archives - Archives (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Gerstein Science - Periodical Stacks (7) 7
Engineering & Comp. Sci. - Stacks (6) 6
Gerstein Science - Theses (6) 6
UTL at Downsview - May be requested (5) 5
UofT at Mississauga - Stacks (5) 5
Gerstein Science - Bindery (4) 4
Earth Sciences (Noranda) - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
Physics - Theses (2) 2
Scarborough Hospital - General (2) 2
St. Michael's Hospital - Periodical Stacks (2) 2
St. Michael's Hospital - Storage (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Curriculum Resources (1) 1
Providence Healthcare - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (690901) 690901
German (11193) 11193
Japanese (9265) 9265
French (6239) 6239
Russian (5452) 5452
Chinese (4180) 4180
Spanish (3347) 3347
Italian (2677) 2677
Polish (1533) 1533
Portuguese (1465) 1465
Korean (989) 989
Czech (935) 935
Hungarian (406) 406
Dutch (291) 291
Ukrainian (289) 289
Swedish (266) 266
Danish (257) 257
Romanian (254) 254
Turkish (210) 210
Bulgarian (196) 196
Slovak (166) 166
Persian (159) 159
Norwegian (129) 129
Serbian (103) 103
Finnish (100) 100
Croatian (83) 83
Indonesian (65) 65
Hebrew (61) 61
Arabic (27) 27
Lithuanian (17) 17
Bosnian (14) 14
Icelandic (13) 13
Urdu (10) 10
Slovenian (9) 9
Afrikaans (8) 8
Greek (7) 7
Malay (4) 4
Catalan (3) 3
Hindi (2) 2
Macedonian (2) 2
Welsh (2) 2
Armenian (1) 1
Belarusian (1) 1
Breton (1) 1
Estonian (1) 1
Latvian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes technology & therapeutics, ISSN 1520-9156, 1999
Journal
Scientific Reports, ISSN 2045-2322, 2013, Volume 3, Issue 1, p. 1377
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2012, Volume 165, Issue 5, pp. 1361 - 1374
BACKGROUND AND PURPOSE Pentoxifylline is in clinical trials for non‐alcoholic fatty liver disease and diabetic nephropathy. Metabolic and hepatic effects of... 
glucose | ChREBP | pentoxifylline | methylxanthine | fatty liver | drug‐induced liver injury | obesity | drug-induced liver injury | TRIGLYCERIDE TRANSFER PROTEIN | ELEMENT-BINDING PROTEIN | FACTOR-KAPPA-B | NONALCOHOLIC STEATOHEPATITIS | DIET-INDUCED OBESITY | PARTIAL LEPTIN DEFICIENCY | CYCLIC-AMP | IN-VIVO | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | METABOLIC-DISORDERS | Glucose Transporter Type 2 - genetics | Humans | Intestinal Absorption - drug effects | Male | Adipocytes - drug effects | Glycolysis - drug effects | Jejunum - metabolism | Glycolysis - genetics | Jejunum - drug effects | Inflammation - metabolism | Lipogenesis - genetics | Liver - drug effects | Pentoxifylline - pharmacology | Biomarkers - metabolism | Fatty Liver - metabolism | Liver - metabolism | Biomarkers - blood | Blood Glucose - drug effects | Cell Line, Tumor | Glucose - metabolism | Blood Glucose - genetics | Mice, Obese | Transaminases - blood | Mice | Oxidative Stress - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - genetics | Glucose Tolerance Test - methods | Diabetes Mellitus, Type 2 - metabolism | Obesity - genetics | Glucose Transporter Type 2 - metabolism | Sodium-Glucose Transporter 1 - genetics | Glycolysis - physiology | Lipids - blood | Sodium-Glucose Transporter 1 - metabolism | Nuclear Proteins - genetics | Sterol Regulatory Element Binding Protein 1 - metabolism | Fatty Liver - genetics | Mice, Inbred C57BL | Oxidative Stress - genetics | Glucose - genetics | Nuclear Proteins - metabolism | Transcription Factors - genetics | Obesity - metabolism | Transcription Factors - metabolism | Animals | Intestinal Absorption - genetics | Sterol Regulatory Element Binding Protein 1 - genetics | Adipocytes - metabolism | Lipogenesis - drug effects | Triglycerides - blood | Inflammation - genetics | Oxidative Stress | Biological Markers | Liver | Lipids | Adipocytes | Glucose | Intestinal Absorption | Life Sciences | Jejunum | Diabetes Mellitus, Type 2 | Lipogenesis | Pharmaceutical sciences | Obesity | Glucose Tolerance Test | Glucose Transporter Type 2 | Sodium-Glucose Transporter 1 | Blood Glucose | Inflammation | Triglycerides | Pharmacology | Nuclear Proteins | Pentoxifylline | Fatty Liver | Transaminases | Glycolysis | Transcription Factors | Sterol Regulatory Element Binding Protein 1 | Research Papers
Journal Article
Diabetologia, ISSN 1432-0428, 2018, Volume 61, Issue 10, pp. 2087 - 2097
The concentration of glucose in plasma is held within narrow limits (4–10 mmol/l), primarily to ensure fuel supply to the brain. Kidneys play a role in glucose... 
GLUTs | Human Physiology | SGLTs | Metabolic Diseases | Internal Medicine | Glucose | Review | Type 2 diabetes mellitus | Gliflozins | Kidney | Proximal tubule | Phlorizin | Inhibitors | Medicine & Public Health | SODIUM | FANCONI-BICKEL-SYNDROME | LOW-AFFINITY | NA+/GLUCOSE COTRANSPORTER SGLT2 | TRANSPORT | THERAPEUTIC TARGET | ENDOCRINOLOGY & METABOLISM | PHLORHIZIN | EXPRESSION | BINDING | Glucose Transporter Type 2 - genetics | Humans | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Homeostasis | Diabetes Mellitus, Type 2 - metabolism | Sodium-Glucose Transporter 1 - physiology | Sodium-Glucose Transporter 1 - genetics | Glycosuria - metabolism | Hypoglycemic Agents - pharmacology | Mice, Knockout | Sodium-Glucose Transporter 2 - physiology | Kidney - metabolism | Animals | Glucose Transporter Type 2 - physiology | Drug Design | HEK293 Cells | Kidney Tubules, Proximal - metabolism | Glucose - metabolism | Mice | Blood Glucose - metabolism | Kidney Tubules - metabolism | Phlorhizin - pharmacology | Sodium-Glucose Transporter 2 - genetics | Type 2 diabetes | Medical colleges | Analysis | Physiological aspects | Hypoglycemic agents | Dextrose | Membrane proteins | Glucose transporter | Urine | Excretion | Intravenous administration | Renal function | Kidneys | Diabetes mellitus | Reabsorption | Sodium | Physiology | Diabetes | Diabetes mellitus (non-insulin dependent)
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2012, Volume 7, Issue 2, p. e30555
Background: Canagliflozin is a sodium glucose co-transporter (SGLT) 2 inhibitor in clinical development for the treatment of type 2 diabetes mellitus (T2DM).... 
SELECTIVE SGLT2 INHIBITOR | SODIUM | HOMEOSTASIS | HYPERGLYCEMIA | DAPAGLIFLOZIN | TRANSPORTERS | MULTIDISCIPLINARY SCIENCES | INSULIN-SECRETION | COTRANSPORTER | PROXIMAL TUBULAR CELLS | T-1095 | Thiophenes - therapeutic use | Diabetes Mellitus, Experimental - drug therapy | Humans | Body Weight - drug effects | Male | Muscle, Skeletal - metabolism | Muscle, Skeletal - cytology | Hyperglycemia - drug therapy | Sodium-Glucose Transporter 1 - genetics | Muscle, Skeletal - drug effects | Hyperglycemia - pathology | Sodium-Glucose Transport Proteins - metabolism | Glucosides - therapeutic use | Weight Gain - drug effects | Sodium-Glucose Transporter 1 - metabolism | Diabetes Mellitus, Experimental - metabolism | Kidney - physiopathology | Sodium-Glucose Transport Proteins - genetics | CHO Cells | Sodium-Glucose Transporter 2 - genetics | Cricetinae | Glucose Tolerance Test | Kidney - drug effects | Sodium-Glucose Transporter 2 - metabolism | Mice, Inbred C57BL | Cells, Cultured | Rats | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Hyperglycemia - metabolism | Rats, Zucker | Animals | Canagliflozin | Diabetes Mellitus, Experimental - pathology | Mice, Obese | Mice | Blood Glucose - metabolism | Type 2 diabetes | Glucose metabolism | Obesity | Blood sugar | Analysis | Body weight | Glycosylated hemoglobin | Diabetes therapy | Cell culture | Animal models | Renal function | Laboratories | Liver | Homeostasis | Fuel consumption | Diabetic neuropathy | Glucose | Oocytes | Hyperglycemia | Rodents | Hemoglobin | Glucose transporter | Excretion | Kidneys | Secretion | Research & development--R&D | Diabetes mellitus | Pharmacology | Insulin | Body weight gain | Myoblasts | Beta cells | Sodium | Weight reduction | Insulin resistance | Diabetes | Mutation | Transporter | Kidney transplantation | Pharmaceuticals | Research & development | R&D
Journal Article
by Pogue, Janice and Riddle, Matthew C and Chazova, I and Gilbert, R and Gomis, R and Pīrāgs, V and Bogaty, P and Corson, M and Harper, W.L and Cukierman-Yaffee, T and MacRae, S and Alvarez, N and Amuchastegui, M and Bello, F and Caccavo, A and Calveira, M and Camino, A and Cardone, M and Corinaldesi, F and Crespo, C and Fares Taie, A and Fernandez, A and Ferrari, N and Gutierrez, N and Hasbani, E and Hrabar, A and Lobo Marquez, L and Lugo, M and Mainini, S and Manzano, R and Mendez, N and Odetto, I and Polari, P and Ramirez, A and Sanchez, R and Smith Casabella, T and Streitenberger, P and Villamil, A and Amerena, J and Farshid, A and Lefkovits, J and O'Neal, D and Poynten, A and Simpson, R and Teede, H and Tiong, F and Waddell-Smith, K and Blocher, J and Brath, H and Breuss, J and Jankovic, V and Kann, T and Placher-Sorko, G and Sonnenfeld, M and Vetter, B and Wallner, F and Lazareva, I and Delana, J and Feitosa, G and Garcia, V and Kanedlai, N and Mothe, F and Ninno, T and Oliveira, C and Oliveira, O and Roldan, F and Bailey, A and Belanger, A and Carlson, B and Chagnon, P and Chessex, C and Crepeau, J and Dube, F and Gosselin, G and Harper, W and Ho, K and Hramiak, I and Hutchinson, A and Langlois, M and Lavoie, M and Mercier, M and Nawaz, S and O'Keefe, D and Pruneau, G and Raby, K and Richard, C and Steinson, D and VanRossum, N and Warnica, W and Galloso, R and Stockins, B and Chen, Y and Gao, X and Ji, L and Jia, W and Li, Q and Li, Y and Ling, Y and Lu, B and Peng, Y and ... and unav and The ORIGIN Trial Investigators and ORIGIN Trial Investigators
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3
Journal Article
Diabetologia, ISSN 1432-0428, 2018, Volume 61, Issue 10, pp. 2079 - 2086
Sodium–glucose cotransporters SGLT1 (encoded by SGLT1, also known as SLC5A1) and SGLT2 (encoded by SGLT2, also known as SLC5A2) are important mediators of... 
Heart failure | Intestinal glucose transport | Type 2 diabetes | Human Physiology | Sodium–glucose cotransporter | Metabolic Diseases | Internal Medicine | Chronic kidney disease | Review | Drug development | Medicine & Public Health | Type 1 diabetes | Inhibitor | Renal glucose transport | KIDNEY-DISEASE | OXYGEN-CONSUMPTION | GL